This afternoon we watched Henry Schein drop -1.5% to a price of $67.97 per share. The Mid-Cap Medical Specialities company is now trading -5.9% below its average target price of $72.23. Analysts have set target prices ranging from $55.0 to $83.0 per share for Henry Schein, and have given the stock an average rating of hold.
Henry Schein has an average level of shares sold short, at 7.4% of its total share float. The stock's short ratio (also called days to cover) is 4.75. Only 0.87% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.
Institutional investors own 109.6% of Henry Schein's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Henry Schein
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 11% | 12,931,701 | $878,967,732 |
| 2025-03-31 | Kohlberg Kravis Roberts & Co. L.P. | 10% | 12,016,714 | $816,776,065 |
| 2025-06-30 | Blackrock Inc. | 6% | 7,302,756 | $496,368,334 |
| 2025-06-30 | Artisan Partners Limited Partnership | 5% | 6,462,204 | $439,236,013 |
| 2025-06-30 | JPMORGAN CHASE & CO | 5% | 6,252,743 | $424,998,949 |
| 2025-03-31 | State Street Corporation | 4% | 5,363,053 | $364,526,718 |
| 2025-06-30 | American Century Companies Inc | 4% | 4,558,790 | $309,860,961 |
| 2025-06-30 | Invesco Ltd. | 4% | 4,546,935 | $309,055,177 |
| 2025-03-31 | Palestra Capital Management LLC | 3% | 3,999,490 | $271,845,340 |
| 2025-03-31 | FMR, LLC | 3% | 3,715,456 | $252,539,548 |
